Latest posts tagged with #ASH2023 on Bluesky
Really hoping next year's #ASH2023 lines up with the San Diego #SantaRun once again. Running with 6,000 santas was a ton of fun!
Very happy to have had the opportunity to present our work at #ASH23 #ASH2023. Thanks for everyone who attended & asked questions. I've really enjoyed the whole meeting so far in the San Diego sunshine and its been great to (re)connect with so many people!
#ASH2023 Amazing to see how work to understand the birth defects associated with thalidomide and how thalidomide analogs work in #myeloma has lead to the Novartis Institute identifying CRBN based WIZ degraders to reverse the phenotype of sickle cell anemia
Great comment at #ASH2023, βDonβt consider something irreversible unless the correct target is targetedβ
#ASH2023 #myeloma sadly didnβt get a picture, they are very cool, but super cool antigen quantitation by dSTORM imaging from the wurtzberg group by Umair Munawar. Showing mutations in TP53 and KRAS can alter the surface expression of immunotherapy target antigens
#ASH2023 #myeloma Really important work on the value of blood based MRD by Bruno Paivaβs group with BloodFlow. Question is will it be flow or mass-spec M-protein tracking but clearly the future of disease monitoring
Great talk at #ASH2023 on the spatial distribution of multiple myeloma from Marc-Andrea Baertsch from the Heidelberg MM group. Four different tumor plasma cell distributions
$BLUE gene therapy and $VRTX/ $CRSP gene-editing therapy for sickle cell disease both approved in the US. Looking forward to data updates and conversations at #ASH2023 www.fda.gov/news-events/...
"Meet Red Nucleus at the American Society of Hematology conference #ASH2023". Image created by our in-house animation team of blood cells and white blood cells.
Attending #ASH2023 this week? We're excited to see you there!
Reach out to the Red Nucleus team in San Diego, via email at info@rednucleus.com, or our website rednucleus.com/contact-us/?...
π΄π§
#ASH23 #ASH #hematology
Visit us at #ASH2023 in booth π 3405 and learn more about our diagnostic methods to predict outcomes for aGVHD.
π½ Download the white paper by Steve Kleiboeker, PhD.
www.eurofins-viracor.com/clinical/our...
#ASH23 #aGVHD #GVHD #HCT
With our ExPeCTβ’ CAR T test, we're proud to be at the forefront of pediatric cancer testing, offering advanced diagnostic solutions to improve outcomes for children battling #leukemia.
READ ABOUT IT π
www.eurofins-viracor.com/clinical/new...
#BigJourneySmallSteps #ViracorExPeCT #ASH2023 #ASH23
Anyone else here on bluesky attending #ASH2023 #ASH23 in San Diego in 3(!) days? #hematology #blood #molbio #science #AML π§ͺ
Join us during #ASH2023 for our Meet the Scientists sessions at booth# π 3405.
Speak with our scientific leadership about our diagnostics::
π§ͺ CAR T-cell, aGVHD, TA-TMA, & more.
Booth schedule and more π π
www.eurofins-viracor.com/clinical/new...
#ASH23 #HemOnc #fellowshipmatch2024 #HemOncFellows
π₯ WEBINAR | 12/14, 12-1pm CST
Discovering & Developing Next Generation Diagnostic Tools for the Early Detection of TA-TMA
The work of Dr. Jodele & her team has brought to light significant insights into identifying high-risk patients facing this.
attendee.gotowebinar.com/register/355...
#ASH2023
This has been a pivotal year for us as we've entered the clinical diagnostics oncology space, & we're thrilled about our debut @ #ASH2023! π€ Let's CONNECT!
π§ͺ ExPeCT anti-CD19 CAR T assay
π§ͺ TA-TMA assays (sC5b9 - CH50)
π Booth# 3405
π€ www.eurofins-viracor.com/clinical/new...
#Oncology #CARTcell
When it comes to #CARTcell therapy for peds patients, several factors need to be considered during lab testing to ensure optimal treatment outcomes.
Our ExPeCTβ’ anti-CD19 CAR T-cell assay could be a key factor.
LEARN MORE π
www.eurofins-viracor.com/clinical/new...
#BigJourneySmallSteps #ASH2023
Finally booked my flights to Boston for #CellBio2023 and San Diego for #ASH2023. Looking forward to catching up with my old friends π«Άπ« and meeting new ones! Also excited to meet some of my πβοΈ family. π€©π #NewPI